New norovirus vaccine approach may help treat other RNA viruses
Base to Base biotech podcast 72: Cell-free DNA bioproduction
KTU chemists develop dual-action compounds to fight cancer
RSV antiviral drug receives FDA approval for phase II trial
New data from DM1 study
Synaptiq Therapeutics launches with acquisition of SYN-001 programme
Collaboration to develop first medicine for newly identified ReNU syndrome
Body’s natural recycling system could help reduce inflammation
Crystalys Therapeutics raises $130m for gout treatment
Boost to biotech in Virginia with lab capacity increase
AI and sleep analysis help early diagnosis of Alzheimer’s
Taiwan positions itself as global biotech innovation partner at BIO Asia-Taiwan 2026